Skip to Main Content

Author Details

Ashani T Weeraratna
Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine
1992
134
50
PMIDPaper TitleJournal TitlePublished Year
36593156Changing the culture for the future: time to take brain drain in academics seriously.Trends Cell Biol2023
37671471A Wrinkle in TIME: How Changes in the Aging ECM Drive the Remodeling of the Tumor Immune Microenvironment.Cancer Discov2023
37093838Diversity, equity, and inclusion in the melanoma research community.Pigment Cell Melanoma Res2023
36593156Changing the culture for the future: time to take brain drain in academics seriously.Trends Cell Biol2023
37468627Diverse clonal fates emerge upon drug treatment of homogeneous cancer cells.Nature2023
37205503Age-related increases in IGFBP2 increase melanoma cell invasion and lipid synthesis.bioRxiv2023
37331435Collagen VI deposition mediates stromal T cell trapping through inhibition of T cell motility in the prostate tumor microenvironment.Matrix Biol2023
37183634Correction: sFRP2 Supersedes VEGF as an Age-related Driver of Angiogenesis in Melanoma, Affecting Response to Anti-VEGF Therapy in Older Patients.Clin Cancer Res2023
37059066Fibroblasts in cancer: Unity in heterogeneity.Cell2023
37671471A Wrinkle in TIME: How Changes in the Aging ECM Drive the Remodeling of the Tumor Immune Microenvironment.Cancer Discov2023
37059066Fibroblasts in cancer: Unity in heterogeneity.Cell2023
37183634Correction: sFRP2 Supersedes VEGF as an Age-related Driver of Angiogenesis in Melanoma, Affecting Response to Anti-VEGF Therapy in Older Patients.Clin Cancer Res2023
37468627Diverse clonal fates emerge upon drug treatment of homogeneous cancer cells.Nature2023
37205503Age-related increases in IGFBP2 increase melanoma cell invasion and lipid synthesis.bioRxiv2023
37331435Collagen VI deposition mediates stromal T cell trapping through inhibition of T cell motility in the prostate tumor microenvironment.Matrix Biol2023
37093838Diversity, equity, and inclusion in the melanoma research community.Pigment Cell Melanoma Res2023
35144882Shared genetic and epigenetic changes link aging and cancer.Trends Cell Biol2022
35650435Stromal changes in the aged lung induce an emergence from melanoma dormancy.Nature2022
36280724ClampFISH 2.0 enables rapid, scalable amplified RNA detection in situ.Nat Methods2022
36402771Feedback between mechanosensitive signaling and active forces governs endothelial junction integrity.Nat Commun2022
35144882Shared genetic and epigenetic changes link aging and cancer.Trends Cell Biol2022
35650435Stromal changes in the aged lung induce an emergence from melanoma dormancy.Nature2022
36402771Feedback between mechanosensitive signaling and active forces governs endothelial junction integrity.Nat Commun2022
36280724ClampFISH 2.0 enables rapid, scalable amplified RNA detection in situ.Nat Methods2022
33262126Myeloid-Derived Suppressor Cells Are a Major Source of Wnt5A in the Melanoma Microenvironment and Depend on Wnt5A for Full Suppressive Activity.Cancer Res2021
33545064Melanoma models for the next generation of therapies.Cancer Cell2021
33720046The dark side of daylight: photoaging and the tumor microenvironment in melanoma progression.J Clin Invest2021
33262126Myeloid-Derived Suppressor Cells Are a Major Source of Wnt5A in the Melanoma Microenvironment and Depend on Wnt5A for Full Suppressive Activity.Cancer Res2021
33414132The State of Melanoma: Emergent Challenges and Opportunities.Clin Cancer Res2021
34788629Evaluating the impact of age on immune checkpoint therapy biomarkers.Cell Rep2021
35187538HSP70 inhibition blocks adaptive resistance and synergizes with MEK inhibition for the treatment of NRAS-mutant melanoma.Cancer Res Commun2021
34433020Evaluating the impact of age on immune checkpoint therapy biomarkers.Cell Rep2021
35146482A Series of BRAF- and NRAS-Driven Murine Melanoma Cell Lines with Inducible Gene Modulation Capabilities.JID Innov2021
33720046The dark side of daylight: photoaging and the tumor microenvironment in melanoma progression.J Clin Invest2021
33545064Melanoma models for the next generation of therapies.Cancer Cell2021
35187538HSP70 inhibition blocks adaptive resistance and synergizes with MEK inhibition for the treatment of NRAS-mutant melanoma.Cancer Res Commun2021
35146482A Series of BRAF- and NRAS-Driven Murine Melanoma Cell Lines with Inducible Gene Modulation Capabilities.JID Innov2021
34788629Evaluating the impact of age on immune checkpoint therapy biomarkers.Cell Rep2021
34433020Evaluating the impact of age on immune checkpoint therapy biomarkers.Cell Rep2021
33414132The State of Melanoma: Emergent Challenges and Opportunities.Clin Cancer Res2021
31615864Normal Aging and Its Role in Cancer Metastasis.Cold Spring Harb Perspect Med2020
35694033A glitch in the matrix: Age-dependent changes in the extracellular matrix facilitate common sites of metastasis.Aging Cancer2020
31836838How the ageing microenvironment influences tumour progression.Nat Rev Cancer2020
31615864Normal Aging and Its Role in Cancer Metastasis.Cold Spring Harb Perspect Med2020
32032511Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma.Mol Cell2020
33097493sFRP2 Supersedes VEGF as an Age-related Driver of Angiogenesis in Melanoma, Affecting Response to Anti-VEGF Therapy in Older Patients.Clin Cancer Res2020
32931737Completing the Great Unfinished Symphony of Cancer Together: The Importance of Immigrants in Cancer Research.Cancer Cell2020
32816861The Race toward Equity: Increasing Racial Diversity in Cancer Research and Cancer Care.Cancer Discov2020
33088423Deconstructing tumor heterogeneity: the stromal perspective.Oncotarget2020
32514172Preserve junior faculty in biomedical sciences during and after the pandemic.Nat Med2020
  • 1 - 50 of 268

Recommended Authors

Shruthy Suresh
Memorial Sloan Kettering Cancer Center
Career Start Year 2013
Number of shared co-authors 2
Daniel J McGrail
Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic
Career Start Year 2012
Number of shared co-authors 2
Manoela Tiago
Thomas Jefferson University
Career Start Year 2011
Number of shared co-authors 7
Giuseppina Claps
Institut National de la Sante et de la Recherche Medicale (INSERM) U
Career Start Year 2010
Number of shared co-authors 6
Aleksandra M Michalowski
Center for Cancer Research, National Cancer Institute
Career Start Year 2010
Number of shared co-authors 6
Eva P??rez-Guijarro
National Cancer Institute, National Institutes of Health (NIH)
Career Start Year 2009
Number of shared co-authors 12
Lawrence N Kwong
The University of Texas MD Anderson Cancer Center
Career Start Year 2007
Number of shared co-authors 15
Vijay Walia
National Center for Toxicological Research
Career Start Year 2006
Number of shared co-authors 9
Jonathan Chou
University of California san francisco
Career Start Year 2005
Number of shared co-authors 1
Harriet M Kluger
Yale School of Medicine
Career Start Year 2003
Number of shared co-authors 14
Chi-Ping Day
Center for Cancer Research, National Cancer Institute
Career Start Year 2002
Number of shared co-authors 16
Yongmei Feng
Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2002
Number of shared co-authors 11
Susan L Woods
Adelaide Medical School, University of Adelaide
Career Start Year 2002
Number of shared co-authors 4
Daniel Zingg
Netherlands Cancer Institute
Career Start Year 2001
Number of shared co-authors 7
Jun Yao
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 4
Hae-Ock Lee
College of Medicine, The Catholic University of Korea
Career Start Year 1996
Number of shared co-authors 0
William M Gallagher
All-Island Cancer Research Institute, UCD Conway Institute, University College Dublin
Career Start Year 1996
Number of shared co-authors 6
Jan Paul Medema
Oncode Institute
Career Start Year 1993
Number of shared co-authors 2
Craig Gedye
Hunter Medical Research Institute, University of Newcastle
Career Start Year 1993
Number of shared co-authors 0
Levi A Garraway
Broad Institute of Harvard and MIT
Career Start Year 1991
Number of shared co-authors 15
Roger Chammas
Instituto do Cancer do Estado de Sao Paulo, Faculdade de Medicina de Sao Paulo
Career Start Year 1989
Number of shared co-authors 0
Emile E Voest
The Netherlands Cancer Institute
Career Start Year 1989
Number of shared co-authors 2
Enzo Medico
Candiolo Cancer Institute, Fondazione del Piemonte per l'Oncologia (FPO) - IRCCS
Career Start Year 1988
Number of shared co-authors 0
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 3
William C Hahn
Broad Institute of MIT and Harvard, USA Dana-Farber Cancer Institute
Career Start Year 1987
Number of shared co-authors 8
Daniel S Peeper
Netherlands Cancer Institute
Career Start Year 1987
Number of shared co-authors 12
Colin R Goding
Ludwig Institute for Cancer Research, University of Oxford
Career Start Year 1983
Number of shared co-authors 7
Dave S B Hoon
Saint John's Cancer Institute at Saint John's Health Center
Career Start Year 1982
Number of shared co-authors 16
Menashe Bar-Eli
The University of Texas MD Anderson Cancer Center
Career Start Year 1975
Number of shared co-authors 9
Norman E Sharpless
National Cancer Institute
Career Start Year 1945
Number of shared co-authors 4

Collaborators

Michael P O'Connell
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 23
Meenhard Herlyn
Ellen and Ronald Caplan Cancer Center, The Wistar Institute
Co-authored papers 22
Andrew V Kossenkov
The Wistar Institute
Co-authored papers 12
Kevin G Becker
National Institute on Aging, National Institutes of Health
Co-authored papers 11
Nicholas W Wood
UCL Queen Square Institute of Neurology
Co-authored papers 10
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 7
Jennifer A Wargo
Co-authored papers 7
Marcus Bosenberg
Yale School of Medicine
Co-authored papers 6
Yiling Lu
Co-authored papers 6
Stephen M Hewitt
Center for Cancer Research, National Cancer Institute
Co-authored papers 6
David W Speicher
Co-authored papers 6
Zhi Wei
Co-authored papers 5
Michael A Davies
The University of Texas MD Anderson Cancer Center
Co-authored papers 5
Antoni Ribas
University of California Los Angeles (university of california los angeles)
Co-authored papers 5
Gao Zhang
Co-authored papers 5
Reinhard Dummer
University Hospital Zurich
Co-authored papers 4
Elizabeth M Jaffee
Convergence Institute, Johns Hopkins University
Co-authored papers 4
Georgina V Long
Co-authored papers 4
Andrew E Aplin
Thomas Jefferson University
Co-authored papers 4
Ben Ho Park
Vanderbilt University Medical Center
Co-authored papers 3
Paul S Meltzer
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 3
Stephen B Baylin
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
Co-authored papers 3
Dirk Schadendorf
Co-authored papers 3
Paul H Duray
National Cancer Institute, National Institutes of Health
Co-authored papers 3
Jie Zhang
Co-authored papers 3
Phil F Cheng
University Hospital of Zurich
Co-authored papers 3
Glenn Merlino
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 3
Denis Wirtz
Johns Hopkins University
Co-authored papers 3
Katherine L Nathanson
Perelman School of Medicine, University of Pennsylvania, USA Abramson Cancer Center
Co-authored papers 3
Yuan Jiang
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
Release 1.2